Aminated fullerene for comprehensive dry eye therapy: Promoting epithelial-barrier reconstruction and nerve regeneration by suppressing oxidation and inflammation
- 12 April 2025
- journal article
- Published by Elsevier in Biomaterials
- Vol. 321, 123329
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2024YFC2510900/2024YFC2510904)
- National Natural Science Foundation of China (82171033, 82371037)
This publication has 85 references indexed in Scilit:
- An Antioxidative and Active Shrinkage Hydrogel Integratedly Promotes Re‐Epithelization and Skin Constriction for Enhancing Wound ClosureAdvanced Materials, 2024
- Genomic instability and eye diseasesAdvances in Ophthalmology Practice and Research, 2023
- Novel drug delivery systems for the management of dry eyeAdvanced Drug Delivery Reviews, 2022
- Rapid and quantitative detection of tear MMP-9 for dry eye patients using a novel silicon nanowire-based biosensorBiosensors and Bioelectronics, 2022
- Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndromeBiomaterials, 2022
- A Weak Link with Actin Organizes Tight Junctions to Control Epithelial PermeabilityDevelopmental Cell, 2020
- Fullerene-based delivery systemsDrug Discovery Today, 2019
- IL-17RC: a partner in IL-17 signaling and beyondSeminars in Immunopathology, 2009
- Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndromeExperimental Eye Research, 2008
- Molecular mechanisms of N -acetylcysteine actionsCellular and Molecular Life Sciences, 2003